PUGLIESE, NOVELLA
 Distribuzione geografica
Continente #
AS - Asia 2.873
NA - Nord America 2.496
EU - Europa 1.829
SA - Sud America 332
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 88
OC - Oceania 8
Totale 7.786
Nazione #
US - Stati Uniti d'America 2.386
SG - Singapore 1.111
RU - Federazione Russa 818
CN - Cina 589
VN - Vietnam 578
IT - Italia 483
BR - Brasile 256
HK - Hong Kong 209
DE - Germania 128
BD - Bangladesh 111
FR - Francia 94
NL - Olanda 69
GB - Regno Unito 57
CA - Canada 56
IN - India 50
JP - Giappone 50
FI - Finlandia 45
KR - Corea 35
CI - Costa d'Avorio 34
MX - Messico 30
AR - Argentina 26
IE - Irlanda 24
SE - Svezia 23
TH - Thailandia 19
EC - Ecuador 17
IQ - Iraq 17
PL - Polonia 17
ZA - Sudafrica 17
AT - Austria 15
TR - Turchia 15
PH - Filippine 14
UA - Ucraina 14
ID - Indonesia 10
TW - Taiwan 10
PK - Pakistan 9
CO - Colombia 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
ES - Italia 6
LT - Lituania 6
MA - Marocco 6
NP - Nepal 6
CL - Cile 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
RS - Serbia 4
SC - Seychelles 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
MY - Malesia 3
PA - Panama 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BW - Botswana 2
BY - Bielorussia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
NC - Nuova Caledonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LV - Lettonia 1
Totale 7.617
Città #
Singapore 565
San Jose 514
Ashburn 232
Moscow 209
Hong Kong 198
Chandler 193
Beijing 168
Ho Chi Minh City 165
Hefei 147
Hanoi 118
Council Bluffs 109
Naples 102
Santa Clara 99
Los Angeles 70
Amsterdam 58
Munich 51
Lauterbourg 49
Dong Ket 46
Dallas 45
The Dalles 45
Tokyo 44
New York 39
Millbury 34
Buffalo 32
Seoul 31
Napoli 30
Frankfurt am Main 28
São Paulo 28
Seattle 27
Rome 26
Des Moines 24
Milan 22
Boston 21
Denver 20
Da Nang 19
Haiphong 19
Lawrence 19
London 17
Montreal 15
Poplar 15
Princeton 15
Helsinki 14
Mexico City 14
Turku 14
Chicago 13
Nanjing 13
Toronto 13
Atlanta 12
Orem 12
Phoenix 12
Kochi 11
Redondo Beach 11
Warsaw 11
Bangkok 10
Wilmington 10
Brooklyn 9
Guayaquil 9
Nuremberg 9
Rio de Janeiro 9
Turin 9
Chennai 8
Dublin 8
Houston 8
Nocera Inferiore 8
Ottawa 8
Shanghai 8
Stockholm 8
Tianjin 8
Biên Hòa 7
Charlotte 7
Hải Dương 7
Lappeenranta 7
Thái Bình 7
Washington 7
Ankara 6
Calgary 6
Can Tho 6
Dhaka 6
Düsseldorf 6
Mumbai 6
Nanchang 6
Norwalk 6
Rose 6
Roubaix 6
San Francisco 6
Baghdad 5
Bengaluru 5
Campinas 5
Falkenstein 5
Florence 5
Guangzhou 5
Johannesburg 5
Mondragone 5
Porto Alegre 5
Pune 5
Salvador 5
Tashkent 5
Vienna 5
Vĩnh Long 5
Afragola 4
Totale 4.169
Nome #
Secondary syphilis mimicking malignancy: A case report and review of literature 219
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 194
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 193
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 190
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma 185
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL 182
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 179
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience 179
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 178
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 172
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma 163
Advanced-stage Hodgkin Lymphoma: US/Chest Radiography for Detection of Relapse in Patients in First Complete Remission—A Randomized Trial of Routine Surveillance Imaging Procedures 161
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 157
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 156
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 155
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 155
Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography 153
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 151
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 150
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study 150
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 150
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 148
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 148
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 144
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 143
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 143
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury 137
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease 137
Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma 137
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 136
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 133
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia 132
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 126
Cyclic Neutropenia Mimicking Crohn's Disease: Two Case Reports and a Narrative Review 124
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 120
Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis 118
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 117
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 115
Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8+ T-cell Autoimmune Disorders: A Case Report 114
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 113
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 111
Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston 110
Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era" 110
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 109
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” 107
Randomized Comparison of Power Doppler Ultrasonography-Guided Core-Needle Biopsy with Open Surgical Biopsy for the Characterization of Lymphadenopathies in Patients with Suspected Lymphoma, 106
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 105
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma 105
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 104
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 104
Ultrasonography-guided core-needle biopsy for newly diagnosed large b-cell lymphomas: Analysis on Diagnostic efficacy and safety in a Italian retrospective study. 99
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers 89
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 88
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 71
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scans 59
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 54
Routine imaging surveillance after frontline ABVD improves outcome in high-risk hodgkinn lymphoma 45
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 43
Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report. 42
Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical‐Hodgkin lymphoma 30
Elastography Enhances the Diagnostic Performance of Conventional Ultrasonography in Differentiating Benign from Malignant Superficial Lymphadenopathies 10
The progression at 24 months (POD24) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification 10
Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline‐induced cardiomyopathy in elderly patients with Hodgkin lymphoma 9
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study 9
Totale 7.786
Categoria #
all - tutte 23.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022274 0 3 11 1 5 14 9 5 21 20 111 74
2022/2023458 34 40 23 18 68 45 7 53 78 63 17 12
2023/2024265 11 32 26 21 13 26 5 59 4 8 34 26
2024/20251.794 56 25 6 22 47 120 173 133 109 239 706 158
2025/20264.234 368 315 453 358 688 130 472 238 494 345 213 160
2026/2027347 165 182 0 0 0 0 0 0 0 0 0 0
Totale 7.786